The neurotransmitter release at synapses underlies major brain functions such as cognition, emotion, and memory. The precise temporal control of the release is essential for healthy brain activities. Soluble NSF attachment protein receptors (SNAREs) are known to be the core fusion machinery in neuro-exocytotic pathways[@b1][@b2][@b3]. SNARE complex formation in the chasm of two membranes is mediated by the cognate coiled-coil motifs on vesicle and target membrane (v- and t-) SNAREs. One such motif from t-SNARE syntaxin 1A, two from t-SNARE SNAP-25, and another from v-SNARE vesicle-associated membrane protein 2 (VAMP2) forms all parallel four-stranded coiled coil, which brings about the apposition of two membranes[@b4][@b5]. The SNARE proteins, however, do not have the required regulatory function that confers the temporal on/off switching capability. A vesicular protein synaptotagmin1 (Syt1) is instead believed to be the key regulator for the temporal control of SNARE-dependent synaptic vesicle fusion[@b6][@b7][@b8]. Syt1 senses the spike of the Ca^2+^-level, which resulted from the action potential, and helps trigger fast fusion[@b9][@b10].

In molecular level, Syt1 is known to bind the membrane[@b11][@b12][@b13] and the SNARE complex[@b14][@b15][@b16] in the presence of Ca^2+^. The importance of the membrane binding has been well described in several *in vivo* studies employing Syt1 mutants[@b17][@b18]. Interestingly, it is recently suggested that Syt1 has an ability to buckle the membrane to create the locally positive curvature[@b19][@b20], which is believed to help membrane fusion[@b21].

What is then the function of Syt1 binding to the SNARE complex? Clues to this question may be found in its interplay with complexin in SNARE binding[@b22][@b23]. Complexins are a family of small soluble proteins that bind to the SNAREpins[@b24][@b25]. The complexin clamp model proposes that complexin binding to the SNAREpin clamps the fusion[@b26][@b27][@b28][@b29] by preventing the membrane-proximal half from complex formation[@b29]. But upon the rise of the Ca^2+^ level, Syt1 displaces complexin from the SNARE complex[@b26][@b28], allowing complete SNARE assembly to a fusion competent SNAREpin[@b30][@b31]. In such a case, Syt1 binding to the SNARE complex could be simply the end product of the competitive displacement of complexin from the SNARE complex.

Mechanistically, it is thought that SNARE complex formation proceeds from membrane-distal N-terminal region towards membrane-proximal C-terminal region[@b2][@b32][@b33][@b34]. Such sequential zippering could facilitate progressive apposition of two opposing membranes. It has been shown that Syt1 interacts with the C-terminal region of the SNARE complex[@b14][@b15][@b35]. However, whether Syt1 only specifically acts on C-terminal SNARE assembly to give a final push on SNARE zippering remains unclear.

In this work, we were able to dissect the effects of Syt1 and Syt1-Ca^2+^ on SNARE zippering by using fluorescence resonance energy transfer (FRET) technology through placing FRET pairs at strategic locations on the t- and v-SNAREs. We concluded that Syt1-Ca^2+^ not only help vesicle docking, but also play roles on C-terminal SNARE complex formation via crosslinking two membranes, which in turn facilitates the fusion pore opening.

Results
=======

C2AB and Ca^2+^ had no effect on N-terminal trans SNARE assembly
----------------------------------------------------------------

Syt1 has two soluble Ca^2+^-binding tandem C2 domains and a single membrane-spanning helix at the C-terminal region that anchors Syt1 to the vesicle membrane[@b6][@b36]. C2AB, a recombinant soluble version of Syt1 lacking the transmembrane part, is often used as an alternative model in a variety of *in vitro* studies[@b19][@b20][@b37]. C2AB is shown to recapitulate not all, but some essential features of Syt1 functions such as Ca^2+^-triggered enhancement of SNARE-driven fusion[@b38]. To test the effect of Syt1 on N-terminal initiation of SNARE assembly, the FRET assay was employed with N-terminal labeled v- and t-SNARE pairs. The cysteine free version of full-length syntaxin 1A (SyxF), VAMP2, and SNAP-25 were used in our system. To generate the N-terminally labeled protein, the N-terminal amino acids I187 of SyxF and G18 of VAMP2, which are both located outside but close to the N-terminal ends of SNARE motifs, were changed to cysteines, and the cysteine mutants SyxF I187C and VAMP2 G18C were labeled with fluorescence donor Alexa Fluor 546 (A546) and acceptor Alexa Fluor 647 (A647), respectively. As shown on SDS-PAGE gels, the labeled proteins run slightly slower than wild type proteins, due to the addition of molecular weight of the dye molecules to the proteins ([Supplementary Figure S1](#s1){ref-type="supplementary-material"}). The labeled t-SNARE, SyxF I187C-A546 combined with SNAP-25, was reconstituted into a population of vesicles (t-vesicles), while VAMP2 G18C-A647 was reconstituted into a separate population of vesicles (v-vesicles, [Figure 1A](#f1){ref-type="fig"}). Here, both t- and v-vesicles contained 45 mol% POPC (1-palmitoyl-2-oleoyl-*sn*-glycero-3-phosphocholine), 15 mol% DOPS (1, 2-dioleoyl-*sn*-glycero-3-phosphatidylserine) and 40 mol% cholesterol, which mimics the lipid composition in synaptic vesicles[@b39]. The lipid to protein ratio was kept to be 200:1 for all measurements. The activities of fluorophore-labeled SNARE proteins were checked by the lipid-mixing assay. The results suggested the dyes did not affect the SNARE activities ([Supplementary Figure S2A](#s1){ref-type="supplementary-material"}).

FRET assay has been widely used to determine whether two fluorophores are within a certain distance of each other[@b40][@b41][@b42][@b43][@b44][@b45][@b46]. When t- and v-vesicles dock or fuse with each other due to the interaction between t- and v-SNAREs, the proximity between A546 on SyxF I187C and A647 on VAMP2 G18C leads to FRET (NN-FRET), results in the increase of the acceptor signal ([Figure 1B](#f1){ref-type="fig"}, red line). On the contrast, the 80% FRET signal will be inhibited during the time course in presence of 10 uM Vps ([Figure 1B](#f1){ref-type="fig"}, black line). When 1 μM C2AB was added to the fusion reaction mixture, however, we did not observe any further stimulation, even in the presence of Ca^2+^ ([Figure 1B](#f1){ref-type="fig"}, green and blue lines). Instead, Ca^2+^caused slight inhibition of NN-FRET ([Figure 1B](#f1){ref-type="fig"}, blue lines). The inhibition was less than a factor of two in initial rates for all Ca^2+^ concentrations studied ([Figure 1C](#f1){ref-type="fig"}), which we might attribute to the self-association of v- and t-vesicles induced by cross-binding of C2B domains in the Ca^2+^ presence[@b47][@b48]. Meanwhile, we also excluded the possibility that the individual factor such as C2AB or Ca^2+^ did not change the donor or acceptor signal under the same condition ([supplementary Figure S3](#s1){ref-type="supplementary-material"}). Thus, the results show that C2AB and C2AB-Ca^2+^ have no stimulatory effects on NN-FRET or vesicle docking. To test whether different FRET probes will affect the FRET signal, we also observed the similar results by using Cy3-labeled SyxF I187C and Cy5-labeled VAMP2 G18C ([Supplementary Figure S4](#s1){ref-type="supplementary-material"}), further confirmed our conclusion. Next, we performed the same experiment at three different lipid concentrations at 0.06, 0.1, and 0.2 mM ([Figure 1D](#f1){ref-type="fig"}). Surprisingly, we observed stronger inhibitory effect by C2AB/Ca^2+^ at high lipid concentration level. We attribute this inhibition to the non-specific aggregation of vesicles caused by C2AB/Ca^2+^, which would reduce the available t- and v- vesicles for SNARE nucleation at N-terminus. Here, we note that soluble VAMP2 (amino acids 1--96, Vps in [Figure 1B](#f1){ref-type="fig"}), which is often used as a competitive inhibitor for SNARE-dependent membrane fusion, does not completely inhibit NN-FRET at 10 μM, different from the complete inhibition observed for other C-terminally labeled SNARE FRET pairs (see below). Overall, the results of NN-FRET assay suggest that C2AB did not involve in stimulating the initiation of SNAREpin zippering, indicating it may play roles during SNARE zippering at the later step.

C2AB and Ca^2+^ facilitates SNARE zippering at the membrane-proximal region
---------------------------------------------------------------------------

Previous studies have already shown that C2AB binds to the membrane proximal region of SNARE core[@b35][@b49] and mutations at the C-terminal SNARE motif of SNAP-25 could also impair the Ca^2+^-triggered neurotransmitter release[@b35][@b50]. Thus, it is anticipated that binding of Syt1 to the C-terminal region of SNARE motif is critical to its function as a Ca^2+^ sensor. To further address the impact of Syt1 binding to the SNARE core, we generated another site-specifically labeled v- and t-SNARE FRET pairs, SyxF Y257C-A546 and VAMP2 K87C-A647, in which labeled sites are localized near the membrane-proximal end of SNARE motifs (MM-FRET pairs) ([Figure 2A](#f2){ref-type="fig"}). With labeled SNAREs only, but without C2AB and Ca^2+^, the rate change of MM-FRET in time course was much slower than that of the NN-FRET assay ([Figure 1](#f1){ref-type="fig"}), indicating that SNARE zippering is indeed sequential, consistent with the zipper model[@b2][@b8][@b32][@b51]. Moreover, the slower rate for MM-FRET implies that the C-terminal zippering step might have higher activation energy barrier. In contrast to the NN-FRET assay, we observed a clear factor of 10 enhancement of the initial rate in MM-FRET when both 1 μM C2AB and 100 μM Ca^2+^were added, while there is no any enhancement observed in the absence of Ca^2+^ ([Figure 2B](#f2){ref-type="fig"}). As expected, Ca^2+^ alone also did not affect the initial rate of the MM-FRET ([Supplementary Figure S5](#s1){ref-type="supplementary-material"}). All these data suggested that role of Syt1 on SNARE core zippering was Ca^2+^ dependent, which was consistent with early findings. Furthermore, the stimulatory effect of C2AB with Ca^2+^ on MM-FRET as well as MM-FRET in the absence of C2AB and Ca^2+^ were completely blocked by 10 μM soluble VAMP2 (Vps) ([Figure 2B](#f2){ref-type="fig"} yellow and black lines), indicating that the stimulation by C2AB and Ca^2+^ is also SNARE-dependent. As shown above, here the lipid-mixing assay was performed again to confirm that fluorescence probes did not affect the activities of SNARE proteins ([Supplementary Figure S2B](#s1){ref-type="supplementary-material"}). In summary, our results show that in the presence of Ca^2+^, C2AB dramatically promotes the SNARE zippering at the membrane-proximal C-terminal region while does not affect the nucleation of SNARE assembly at the N-terminal region ([Figure 1](#f1){ref-type="fig"}). When higher concentration of C2AB (5 μM) used in the assay, similar results for MM-FRET were observed ([Supplementary Figure S6](#s1){ref-type="supplementary-material"}).

C2AB-Ca^2+^stimulates *cis* SNARE assembly assessed by FRET at the ends of transmembrane domains
------------------------------------------------------------------------------------------------

Next, we attached fluorescence probes at or near the C-terminal end of t- and v-SNAREs (SyxFG288C-A546 and VAMP2 T116C-A647, respectively) to further investigate the effects of C2AB and Ca^2+^ on *cis* SNARE assembly, which occurs after fusion pore opening and reflects the coexistence of two transmembrane domains in the same membrane (CC-FRET pairs, [Figure 3A](#f3){ref-type="fig"}). Again, we verified the activities of the C-terminally labeled SNARE pairs by the lipid-mixing assay ([Supplementary Figure S2C](#s1){ref-type="supplementary-material"}). In the CC-FRET assay, as expected, we observed clear Ca^2+^-dependent stimulation of CC-FRET in the presence of 1 μM C2AB and Ca^2+^ ([Figure 3B](#f3){ref-type="fig"}). At 100 μM Ca^2+^, we observed again the same factor of 10 enhancements of the initial rates when compared with that in the absence of C2AB. Furthermore, CC-FRET was completely blocked by 10 μM Vps ([Figure 3B](#f3){ref-type="fig"}, black line). Neither did Ca^2+^ alone in the absence of C2AB, nor did C2AB alone in the absence of Ca^2+^ give any stimulation of CC-FRET ([Supplementary Figure S5C](#s1){ref-type="supplementary-material"}). Thus, our results show that C2AB-Ca^2+^ enhances the rate of *cis* SNARE assembly, which may help to enlarge the fusion pore later.

Membrane is required for C2AB-Ca^2+^to stimulate SNAREpin formation
-------------------------------------------------------------------

It has been reported that enhancement of SNARE assembly by C2AB-Ca^2+^ might be contributed by two ways. One is binding of Syt1 to SNARE complex[@b14], while the other is cross-linking two membrane[@b38][@b48][@b52]. Up to now, however, it remains unclear that which one is dominant in this process. To answer this question, we further studied the effect of C2AB-Ca^2+^ on SNARE complex assembly in the absence of membrane. Interestingly, we did not observe any stimulation of initial rate in MM-FRET with the presence of C2AB-Ca^2+^ when there was no membrane ([Figure 4A](#f4){ref-type="fig"}), indicating that the binding of C2AB-Ca^2+^ to membrane was required. In this study, we also examined whether detergent or lipid affects SNARE-C2AB interaction. Our results clearly showed that both detergent and lipid had little effect on the interaction between SNARE proteins and C2AB ([Supplementary Figure S7](#s1){ref-type="supplementary-material"}). Furthermore, when we removed the acidic lipid from the vesicle membrane to block the binding of C2AB-Ca^2+^ to the membrane, we observed no stimulatory effect on MM-FRET by C2AB-Ca^2+^ ([Figure 4B](#f4){ref-type="fig"}). All these data suggested the sequential assembly of SNARE core region requires two opposite membranes. Moreover, our dynamics light scattering measurement shows only C2AB and Ca^2+^ can efficiently enlarge the size of vesicle particle from 100 nm to 700 nm, indicating that the two opposing membrane bridging by C2AB was Ca^2+^ dependent ([Supplementary Figure S8](#s1){ref-type="supplementary-material"}). To further confirm our conclusions, We interfered the formation of SNARE complex by applying the botulium neurotoxin (BoNT) type A and E digested version of SNAP-25: SNAP-25 BoNT/A and SNAP-25 BoNT/E, in which SNAP-25 is cleaved at amino acid Gln197 and Arg180, respectively. As expected, in absence of Ca^2+^, SNAP25 BoNT/A and BoNT/E both show inhibition in SNARE assembly due to the impairment in SNARE motif of SNAP-25 (green and blue line in [Figure 4C](#f4){ref-type="fig"}). However, we observed that C2AB-Ca^2+^ could still facilitate the SNARE assembly in the presence of membrane though SNARE complex formation has been partially blocked ([Figure 4C](#f4){ref-type="fig"}). We noticed that due to the severe defect in SNARE motif of SNAP-25 BoNT/E, the SNARE assembly with SNAP25 BoNT/E can not achieve the level of wild type in presence of Ca^2+^, even though the stimulatory effect by C2AB and Ca^2+^ is still substantial (dotted blue line in [Figure 4C](#f4){ref-type="fig"}). Thus, we concluded that membrane was required for the SNARE zippering process by Syt1-Ca^2+^ in the SNARE core region.

Discussion
==========

We developed the FRET assay employing fluorescently labeled SNAREs to investigate the function of Syt1 in vesicle exocytosis. With a set of labeled SNAREs for which FRET pairs are site-specifically attached at strategic positions, we were able to dissect the impact of C2AB-Ca^2+^ at three different stages of vesicle fusion: NN-FRET for the nucleation of SNARE assembly, MM-FRET for SNARE zippering at the membrane-proximal region, and CC-FRET for fusion pore opening. When FRET happens between the donor and acceptor dyes, we could observe the enhancement of the acceptor intensity during the time course, while the donor intensity is declining at the same time ([Supplementary Figure S9](#s1){ref-type="supplementary-material"}). Our results show that C2AB alone, in the absence of Ca^2+^, did not influence the kinetics of any of the three steps. However, Syt1 alone can help vesicle docking, indicating that C2AB and Syt1 might have a distinct mechanism to regulate vesicle docking[@b38]. Furthermore, the result show that C2AB in the presence of Ca^2+^ stimulates the kinetics of MM-FRET and CC-FRET with little stimulatory effect on NN-FRET, indicating that C2AB-Ca^2+^ specifically works on the SNARE zippering and the fusion pore opening steps after docking. As we did not see the stimulation in NN-FRET, it excluded the possibility that the enhancement of NN-FRET caused the increase of MM-FRET. Therefore, the results provide the direct *in vitro* evidence that Syt1 may stimulate SNARE zippering specifically at the membrane proximal half. Finally, via using detergent, neutral membrane and SNAP25 mutants, we figured out that the membrane binding by C2AB-Ca^2+^ is required for the enhancement on SNARE complex assembly.

Based on the results of CC-FRET, C2AB-Ca^2+^ appears to stimulate the rate of the fusion pore opening by 10-folds. But the enhancement factor is virtually the same as that of SNARE zippering at the membrane-proximal region detected in the MM-FRET analysis. Therefore, we speculate the rate enhancement in CC-FRET is just the consequence of the stimulation of MM-FRET by C2AB-Ca^2+^. If so, the main function of C2AB and Ca^2+^ might be to stimulate SNARE-zippering at the membrane proximal region, and the observed stimulation of the fusion pore opening may be a collateral consequence of this main thrust at the membrane-proximal region of SNAREs. In our system, we analyzed all the FRET assays and defined the initial rates instead of the rate constants as our data, because the rate constants of the negative control and FRET sample could become the same level when they reach the steady state ([Supplementary Figure S10](#s1){ref-type="supplementary-material"}).

Recently, some *in vivo* study[@b53][@b54] have suggested that Syt1 is required for vesicle docking to the plasma membrane via the interaction with the binary t-SNARE complex. In this work, we have strategically used C2AB, the recombinant soluble version of Syt1, instead of the full length Syt1 in order to suppress its involvement in vesicle docking and single out its effect on SNARE complex formation. As anticipated, we did not observe any enhancement of the rate of NN-FRET by C2AB both in the presence and absence of Ca^2+^ ([Figure 1](#f1){ref-type="fig"}). The main reason for this discrepancy between Syt1 and C2AB may be the lack of the transmembrane anchor in C2AB. A recent study with the single vesicle fusion assay demonstrated that transmembrane anchor is essential for the enhancement of docking by Syt1[@b9].

Combining the current and previously reported results it appears that Syt1 involves every step along the fusion pathway from docking to fusion pore opening ([Figure 5](#f5){ref-type="fig"}). The docking enhancement is mediated by the interaction of Syt1 to t-SNARE[@b9][@b54][@b55], for which anchoring of Syt1 to the vesicle membrane is essential. This interaction appears to be Ca^2+^-independent. Next, C2AB, the tandem C2 domains of Sty1, was specifically involved in stimulating the C-terminal SNARE zippering in the presence of Ca^2+^. We speculate that this step involves the interaction of C2AB with acidic membrane. Thus, C2AB-Ca^2+^ cross-linked two membranes and shorten the distance which is favorable for SNARE zippering.

Finally, C2AB stimulate fusion pore opening. This step also requires Ca^2+^. The molecular interactions underlying this particular action are unclear, and we speculate this could be simply the consequence of the main push on the SNARE zippering at the C-terminal region of Snares. Or, possibly, it does involve further specific interaction between Syt1 and SNAREs, warranting further investigation.

Methods
=======

Plasmid constructs and site-directed mutagenesis
------------------------------------------------

DNA sequences encoding syntaxin 1A (amino acids 1--288 with three cysteines replaced by alanines), VAMP2 (amino acids 1--116 with C103 replaced by alanines), SNAP-25 (amino acids 1--206 with four native cysteines replaced by alanines), soluble VAMP2 (amino acids 1--96) and soluble synaptotagmin-1 C2AB (amino acid 96--421) were inserted into the pGEX-KG vector as N-terminal glutathione S-transferase (GST) fusion proteins. We used the Quick Change site-directed mutagenesis kit (Stratagene) to generate all cysteine mutants, including SyxF I187C, SyxF Y257C, SyxF G288C, VAMP2 G18C, VAMP2 K87C and VAMP2 T116C. Sequencing Facility at Iowa State University confirmed all of the DNA sequences.

Protein expression, purification and labeling
---------------------------------------------

All cysteine mutant recombinant neuronal SNARE proteins, SNAP-25, and C2AB were expressed as N-terminal glutathione-S-transferase fusion proteins. Recombinant proteins were expressed in *Escherichia coli* Rosetta (DE3) pLysS (Novagene). The cells were grown at 37°C in LB medium with 100 μg ml^−1^ ampicillin until the absorbance at 600 nm reached 0.6--0.8. The cells were further grown for overnight after adding IPTG (0.5 mM final concentration) at 16°C. We purified the proteins using glutathione-agarose chromatography. Cell pellets were resuspended in 20 ml PBS, pH 7.4, containing 0.2 v/v% Triton X-100, with final concentrations of 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), 2 mM DTT. Cells were broken by sonication in an ice bath and centrifuged at 15,000 *g* for 30 min at 4°C. The supernatant was mixed with 2 ml glutathione-agarose beads in PBS and nutated in the cold room (4°C) for 2 h. The proteins were then cleaved by thrombin in cleavage buffer (50 mM TrisHCl, 150 mM NaCl, pH 8.0) with 0.8 g per 100 ml *n*-octyl-D-glucopyranoside (OG) for cysteine mutants and SNAP-25, or cleaved by thrombin in cleavage buffer for soluble VAMP2 and C2AB. Purified proteins were examined with 15% SDS-PAGE, and the purity was at least 85% for all proteins.

SyxF and VAMP2 cysteine mutants were labeled with the fluorescence labels Alexa Fluor 546 and Alexa Fluor 647 (Invitrogen) or Cy3 and Cy5 maleimide (Amersham) ([Supplementary Figure S4](#s1){ref-type="supplementary-material"}), respectively. The reaction mixture, with the dye to protein ratio of more than 5:1, was left overnight at 4°C. The free dye was removed using the PD-10 desalting column (Amersham). All labeled proteins were analyzed by the SDS-polyacryamide gel in which the labeled proteins ran a little slower than the wild-type, and the labeling efficiency were over 90% for all proteins ([Supplementary Figure S1](#s1){ref-type="supplementary-material"}).

Membrane reconstitution
-----------------------

The mixture of POPC (1-palmitoyl-2-dioleoyl-sn-glycero-3-phosphatidylcholine), DOPS (1,2-dioleoyl-sn-glycero-3-phosphatidylserine) and Cholesterol (molar ratio of 45:15:40) in chloroform was dried in a vacuum and was resuspended in a buffer (25 mM HEPES/KOH, 100 mM KCl, pH 7.4) to make the total lipid concentration about 25 mM. Protein-free large unilamellar vesicles (\~100 nm in diameter) were prepared by extrusion through polycarbonate filters (Avanti Polar Lipids). For the lipid mixing assay, the t-vesicles contained 2 mol% DiI in replacement of equimolar POPC, whereas the v-SNARE vesicles contained 2 mol% DiD.

Labeled SyxF and SNAP-25, in a molar ratio of 1:1.5, were premixed, and the mixture was left at room temperature for 1 hour to form the complex before the reconstitution. For membrane reconstitution, proteins were mixed with vesicles at the protein to lipid molar ratio of 1:200 with \~0.8 g per 100 ml OG in the buffer at 4°C for 15 min. The mixture was diluted two times with dialysis buffer (25 mM HEPES, 100 mM KCl, pH 7.4), and this diluted mixture was then dialyzed in 2 L dialysis buffer at 4°C for overnight.

For each reaction, there is 10 nmole lipids for each t- and v- vesicle, accordingly, 0.05 nmole SyxF or VAMP2 was needed. For each preparation, we need to reconstitute each vesicle for 10 \~ 20 reactions.

Fluorescence spectrum scanning
------------------------------

The reconstituted vesicles were diluted with HEPES buffer (25 mM HEPES, pH 7.4, 150 mM KCl) to 0.1 mM using a quartz cell of 100 μL with a 2 mm path length. The fluorescence emission spectrum was detected by a Varian Cary Eclipse spectrophotometer, with the excitation wavelength 530 nm and the emission wavelength 550--700 nm for t-vesicles and with the excitation wavelength 630 nm and the emission wavelength 650--800 nm for v-vesicles, respectively. Each spectrum was averaged from five repeated scans with 1 min interval. 1 μM C2AB was added to vesicles with or without 100 mM Ca^2+^. All measurements were performed at 35°C.

Dynamic light scattering
------------------------

DLS experiments were performed on a Protein Solutions DynaPro instrument equipped with a temperature-controlled microsampler, using 10 s acquisition time and 10% laser power. The samples contained 0.1 mM lipid vesicles (POPC/Cholesterol/DOPS = 65:20:15) in 25 mM HEPES (pH 7.4) and 100 mM KCl with various conditions: No addition, 1 μM C2AB and 1 μM C2AB/1 mM Ca^2+^. Samples were prepared in reconstitution buffer in a total volume of 20 μl or incubated with C2AB for 30 minutes in 20°C, and each measurement was done as an average of 30 data points in 20°C. Intensity data from each sample were collected in three replicates and analyzed by the Precision Deconvolve software.

GST Pull-down assay
-------------------

To test binding of C2AB to the ternary SNARE complex, purified soluble syntaxin 1A (SH3, 191--266) and soluble VAMP2 (Vps, 1--96) was mixed with His-tagged SNAP-25 at about 1:1:1 ratio before loading to Ni-NTA beads. The ternary complex was purified following the same procedure described for His-tagged SNAP-25 followed by size-exclusion chromatography using Superdex 200 HR 10/30 column on AKTA system (GE Healthcare). Ternary SNARE fractions was concentrated and binding of GST-C2AB was carried out in dialysis buffer, and dialysis buffer containing 0.1 mM lipids (components are same as the vesicles) or 0.1% triton. The GST Pull-down assay samples were resolved on precast 15% SDS-PAGE and visualized by Coomassie blue staining.

FRET assays
-----------

Reconstituted t-and v-vesicles were mixed at a ratio of 1:1. The final lipid concentrations in the reaction ranged from 0.06 to 0.2 mM. The fluorescence intensity was monitored in two channels with the excitation wavelength of 556 nm and emission wavelengths of 573 and 665 nm for Alexa Fluorescence dyes, respectively, or with the excitation wavelength of 545 nm and emission wavelengths of 570 and 668 nm for AmershamCy Dye. Fluorescence changes were recorded with the Varian Cary Eclipse model fluorescence spectrophotometer using a quartz cell of 100 μL with a 2 mm path length. All measurements were performed at 35°C. FRET value is calculated by the formula: E = Ia/(Ia + Id), where Ia is the fluorescence intensity of the acceptor A647 and Id is that of the donor A546.

Lipid mixing assay
------------------

Reconstituted t vesicle and v-vesicle were mixed at a ratio of 1:1. The total lipid concentration in the reaction is 0.2 mM. The fluorescence intensity was monitored in two channels with the excitation wavelength of 530 nm and emission wavelengths of 570 and 670 nm for DiI and DiD dye pairs, respectively. Fluorescence changes were recorded with the same Varian fluorimeter. All measurements were performed at 35°C.

Statistics analysis
-------------------

Values are given as mean ± SD. For all the data sets requiring a single pairwise comparison, we used Student\'s t test to compute significance. Significance was defined by the criterion \*P \< 0.05, \*\*P \< 0.01.
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![The NN-FRET assay with Syt1 and Ca^2+^.\
(A) The schematic diagram for the NN-FRET assay. SynF I187C-A546 (red) and SNAP-25 (green) are reconstituted to t-vesicles and VAMP2 G18C-A647 (blue) is to v-vesicles. C2AB is shown in pink. (B) The increase of FRET signal was recorded. The red line is the control with labeled SNAREs only without C2AB. The green line represents the NN-FRET assay with 1 μM C2AB and 1 mM EDTA, while the blue line represents the reaction with 1 μM C2AB and 100 μM Ca^2+^. The black line is the negative control with 10 μM soluble VAMP2 (Vps). (C) Relative initial rates of the NN-FRET assays at different Ca^2+^ concentrations. Error bars, which represent standard deviation, were obtained from 3 independent measurements with 3 different preparations. (D) C2AB and C2AB-Ca^2+^show similar effects on the initial rates of N-terminal *trans* SNARE assembly at different lipid concentrations (0.06, 0.10, and 0.20 mM). The initial rate was measured from the slope at time near 0 (\*P \< 0.05, \*\*P \< 0.01, and n.s means not significant).](srep04575-f1){#f1}

![Ca^2+^-dependent stimulation of SNARE zippering by C2AB.\
(A)The schematic diagram for the MM-FRET assay. SyxF Y257C-A546 (red) combined with SNAP-25 (green) are reconstituted to t-vesicles, while VAMP2 K87C-A647 (blue) was reconstituted to v-vesicles. C2AB is shown in pink. (B) Changes of the FRET signal in time after mixing t- and v-vesicles are shown. The red line is the control with labeled SNAREs only without C2AB or Ca^2+^. The green line represents FRET signal with 1 μM C2AB and 1 mM EDTA, while the blue line represents FRET signal with 1 μM C2AB and 100 μM Ca^2+^. The yellow line represents FRET signal with 1 μM C2AB, 100 μM Ca^2+^ and 10 μM Vps. The black line is with 10 μM Vps without C2AB and Ca^2+^. (C) Initial rate of FRET signal in the MM-FRET assays at different Ca^2+^ concentrations. The error bars, which represent standard deviation, were obtained from 3 independent measurements from 3 different preparations (\*P \< 0.05, \*\*P \< 0.01, and n.s means not significant).](srep04575-f2){#f2}

![Ca^2+^-dependent stimulation of *cis* SNARE assembly by C2AB.\
(A) The schematic diagram for the CC-FRET assay. SyxF G288C-A546 (red) combined with SNAP-25 (green) are reconstituted to t-vesicles, while VAMP2 T116C-A647 (blue) was reconstituted to v-vesicles. C2AB is shown in pink. (B) Changes of the FRET signal in time. The red line is the control with labeled SNAREs only without C2AB or Ca^2+^. The green line represents signal with 1 μM C2AB and 1 mM EDTA, while the blue line represents signal with 1 μM C2AB and 100 μM Ca^2+^. The black line is the control with 10 μM Vps. (C) Initial rate of FRET signal in the CC-FRET assays at different Ca^2+^ concentrations. The error bars, which represent standard deviation, were obtained from 3 independent measurements from 3 different preparations (\*P \< 0.05, \*\*P \< 0.01, and n.s means not significant).](srep04575-f3){#f3}

![C2AB-Ca^2+^ stimulates SNAREpin formation via crosslink two opposition membranes.\
(A) MM-FRET in presence of 0.8% OG. The red line is the control with labeled SNAREs only without C2AB or Ca^2+^. The green line represents FRET signal with 0.5 μM C2AB and 100 μM Ca^2+^, while the blue line represents signal with 0.05 μM C2AB and 50 μM Ca^2+^. (B) The MM-FRET with neutral membrane. The red line is the control with labeled SNAREs only without C2AB or Ca^2+^. The green line represents signal with 1 μM C2AB and 1 mM EDTA, while the blue line represents signal with 1 μM C2AB and 100 μM Ca^2+^. (C) MM-FRET with SNAP-25 BoNT/A and BoNT/E. The dotted lines represent MM-FRET with C2AB with Ca^2+^, while the sold lines represent MM-FRET with C2AB only. And the red line is the control with labeled SNAREs with WT SNAP25. The green line is with SNAP25 BoNT/A, while the blue line is with SNAP25 BoNT/E.](srep04575-f4){#f4}

![The model of the stimulatory SNARE zippering by Syt1 and Ca^2+^.\
In this model, syntaxin-1A (red) and SNAP-25 (green) pre-assemble into the binary t-SNARE complex at plasma membrane, while VAMP2 (blue) and Syt1 (pink) are anchored on the vesicle membrane. In the stage of vesicle docking, Syt1 binding to the binary t-SNARE complex facilitates the synaptic vesicle docking with the plasma membrane[@b53][@b54]. The N-terminus of the binary t-SNARE complex then start zippering with the N-terminus of VAMP2, and form into a partially zipped *trans* SNARE complex. Upon the rise of the Ca^2+^ level Syt1-Ca^2+^ interacts with the partially zipped complex and facilitates the SNARE zippering at membrane proximal region, which drives the vesicle fusion.](srep04575-f5){#f5}
